These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29560412)

  • 21. Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition.
    Hwang KD; Bak MS; Kim SJ; Rhee S; Lee YS
    Mol Brain; 2017 Dec; 10(1):57. PubMed ID: 29233183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
    Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
    Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
    Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice.
    Mendell AL; Creighton SD; Wilson HA; Jardine KH; Isaacs L; Winters BD; MacLusky NJ
    Neuroscience; 2020 Mar; 429():185-202. PubMed ID: 31954826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
    Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
    Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
    [No Abstract]   [Full Text] [Related]  

  • 27. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial direct current stimulation does not improve memory deficits or alter pathological hallmarks in a rodent model of Alzheimer's disease.
    Gondard E; Soto-Montenegro ML; Cassol A; Lozano AM; Hamani C
    J Psychiatr Res; 2019 Jul; 114():93-98. PubMed ID: 31054455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients.
    Jin JK; Kim NH; Lee YJ; Kim YS; Choi EK; Kozlowski PB; Park MH; Kim HS; Min do S
    Neurosci Lett; 2006 Oct; 407(3):263-7. PubMed ID: 16973278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
    Ibi D; Hirashima K; Kojima Y; Sumiya K; Kondo S; Yamamoto M; Ando T; Hiramatsu M
    J Alzheimers Dis; 2021; 79(2):639-652. PubMed ID: 33337369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.
    Lanté F; Chafai M; Raymond EF; Pereira AR; Mouska X; Kootar S; Barik J; Bethus I; Marie H
    Neuropsychopharmacology; 2015 Jun; 40(7):1772-81. PubMed ID: 25622751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning.
    Santa-Marinha L; Castanho I; Silva RR; Bravo FV; Miranda AM; Meira T; Morais-Ribeiro R; Marques F; Xu Y; Point du Jour K; Wenk M; Chan RB; Di Paolo G; Pinto V; Oliveira TG
    Cell Rep; 2020 Mar; 30(12):4197-4208.e6. PubMed ID: 32209478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.
    Song JM; DiBattista AM; Sung YM; Ahn JM; Turner RS; Yang J; Pak DT; Lee HK; Hoe HS
    Exp Neurol; 2014 Feb; 252():105-13. PubMed ID: 24316432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.